Rosetta Genomics Net Income Quarterly:
-3.873M for Dec. 31, 2012Rosetta Genomics Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -3.873M |
| June 30, 2011 | -2.512M |
| March 31, 2011 | -1.657M |
| Dec. 31, 2010 | -3.669M |
| Sept. 30, 2010 | -3.372M |
| June 30, 2010 | -4.608M |
| March 31, 2010 | -3.74M |
| Dec. 31, 2009 | -4.041M |
| Sept. 30, 2009 | -3.424M |
| June 30, 2009 | -5.42M |
| March 31, 2009 | -3.619M |
| Dec. 31, 2008 | 1.096M |
| Sept. 30, 2008 | -2.984M |
| June 30, 2008 | -3.697M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
ROSG Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Chembio Diagnostics | 0.4917M |
| Novadaq Technologies | -2.932M |
| Trius Therapeutics | -17.28M |
ROSG Net Income Quarterly Rankings
| Overall |
41st percentile 4662 of 8002 |
| Sector |
33rd percentile 434 of 650 in Healthcare |
| Industry |
14th percentile 52 of 61 in Diagnostics & Research |
ROSG Net Income Quarterly Range, Past 5 Years
| Minimum | -5.420M | Jun 2009 |
| Maximum | 1.096M | Dec 2008 |
| Average | -3.251M |
